Purdue Pharma, Sacklers reach new $7.4 billion opioid settlement
All 50 states as well as the District of Columbia and U.S. territories have approved a $7.4 billion settlement with Purdue Pharma, maker of Oxycontin, over the company’s improper marketing of opioids.
The deal was filed with a federal bankruptcy court by Purdue Pharma officials in March after negotiations with state attorneys general and other stakeholders. If this plan is finalized, payouts will occur over the next 15 years.
In a statement, New York’s Attorney General Letitia James said the plan will “hold the Sackler family accountable” for what she described as their “leading role in fueling the epidemic of opioid addiction and overdoses.”
Under the outlines of the deal, members of the Sackler family who currently own Purdue Pharma are expected to contribute up to $7 billion.
According to the company, a major change from past settlement deals will mean people who wish to sue the Sacklers in civil court for alleged wrong-doing will not be forced to give up those lawsuits.
“Creditors can preserve their right to take legal action against the Sacklers if they do not opt in to the Sackler releases contained in the Plan,” Purdue Pharma said in a statement.
The Sacklers have said repeatedly they did nothing wrong and committed no crimes.
NPR has reached out to members of the Sackler family for comment, but have yet to receive a response.
In a joint statement sent to NPR, attorneys suing Purdue Pharma and the Sacklers praised the deal.
“After five years of litigation and three years in bankruptcy, we are pleased that all 55 eligible states and territories have unanimously agreed to accept,” said members of the National Prescription Opiate Litigation Plaintiffs’ Executive Committee.
They said the deal would add “more than $7 billion in much-needed funds to help communities across the country” recovering from the opioid crisis.
This settlement will have to be approved by a federal bankruptcy court. Experts tell NPR, this version of the deal is likely to be accepted by the courts and by the U.S. Justice Department.
The DOJ’s bankruptcy watchdog agency challenged earlier settlement attempts, leading to the U.S. Supreme Court’s decision to overturn a previous bankruptcy deal with Purdue Pharma and Sacklers in July of 2024.
If finalized, this settlement will add to more than $50 billion in opioid pay-outs by corporations that profited from manufacture, distribution and retail of opioid painkillers at a time when overdoses and drug deaths were skyrocketing in the U.S.
Senate approves cuts to NPR, PBS and foreign aid programs
The Senate voted to approve a $9 billion rescission package aimed at clawing back money already allocated for public radio and television.
Gulf Coast braces for flooding as storm builds into possible tropical depression
The weather system moving across the Florida Panhandle on Wednesday was showing a greater chance of becoming a tropical depression as it moves toward the northern Gulf Coast.
White House says U.S. fentanyl overdose programs will be funded ‘in increments’
CDC staffers worry $140 million in grants could fail to reach state and local overdose programs. The White House officials say the dollars will arrive but won't say when.
Thousands of veterans get help from Congress to save their homes from foreclosure
A bipartisan Congress has come to the rescue of vets at risk of losing their homes, after administrations from both parties tore up VA safety nets for homeowners.
Clawing back foreign aid is tied to ‘waste, fraud and abuse.’ What’s the evidence?
As the Senate prepares to vote on a bill to rescind $40 billion in promised foreign aid, critics of the measure say a thorough governmental review of targeted programs did not actually take place.
How a third parent’s DNA can prevent an inherited disease
An experimental technique that patches defective DNA with donated genetic material helped families at risk of passing rare illnesses to their children.